Glatt has many years of experience and expertise in the taste masking of APIs. With our technologies and formulation approaches, we are able to achieve effective taste masking of drugs. A proven approach is the micro-pelletizing of APIs with the subsequen
Glatt can optimize the active substance release and bioavailability by specific optimized formulation and process methods depending on the physico-chemical property of the active substance.
Glatt can assist you in the formulation and process development to achieve an individual adaptation of the dissolution profile based on the specific drug. We offer fast drug release, modified & delayed release, targeted drug delivery and pulsatile drug re
The development of solid dosage forms is our specialty, with focus on complex formulations and vast expertise for multiparticulate systems. Our development and manufacturing centers with FDA and EU-GMP certification are well equipped for all your requirem
Glatt's facilities and quality-assured processes are GMP compliant manufacturer of placebo and verum for clinical studies in lab and on a pilot scale. Our services include the manufacture of clinical test samples for all solid dosage forms that can be imp
The Glatt MicroPX™ technology (micro pelletizing technology) is a continuous fluidized bed agglomeration procedure for the manufacture of pellets and micropellets with a very high active ingredient content.
Glatt offers expertise is in the development and manufacture of solid dosage forms with particular experience in multiparticulate systems, such as pellets and micropellets, which are further processed into final pharmaceutical dosage form.
The Glatt CPS™ technology (Complex Perfect Spheres Technology) is a further development of the rotor fluidized bed process. It allows for the manufacture of functionalized pellets and micropellets with perfect roundness and surface.
Minakem High Potent site of Mont St Guibert has pioneered from the late 90’s the utilization of containment technology (closed systems) for the production of HAPIs.
The mission of PMC ISOCHEM's R&D consists of chemical, process and analytical Research and Development, up-scaling and production improvement. Thanks to a broad technology platform and lifecycle management experience, PMC ISOCHEM's R&D team takes your product to the next level.
Sub Category See All
API Screening (2)
Clinical Supply (18)
Custom Synthesis (13)
Excipient Screening (12)
Powder / Blend (10)
Salt Screening (6)
Spray Drying (3)
Taste Masking (6)
Tech Transfer (37)
Vaginal / Rectal (3)
Country See All
Companies See All